FDA Proposal Could Restrict Access to Popular GLP-1 Weight Loss Ingredients
The U.S. Food and Drug Administration has signaled a major shift in how some of the world’s most sought-after weight-loss and diabetes drugs are handled, proposing to block outsourcing facilities…






